Hikma Pharmaceuticals Reinforces its Global Portfolio with Purchase of Baxter Healthcare’s US Generic Injectables Business
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 10 (Table of Contents)
Published: 13 Dec-2010
DOI: 10.3833/pdr.v2010.i10.1408 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Hikma Pharmaceuticals has doubled the size of its US business by acquiring Baxter Healthcare’s Multi-Source Injectables (MSI) business for a transaction price of US$112 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS